Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EXO-CD24 by Nano24med for Acute Respiratory Distress Syndrome: Likelihood of Approval
EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Acute Respiratory Distress Syndrome. According to GlobalData,...
EXO-CD24 by Nano24med for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
EXO-CD24 by Nano24med for Acute Respiratory Distress Syndrome: Likelihood of Approval
EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Acute Respiratory Distress Syndrome. According to GlobalData,...